Modulation of Receptor Signaling and Functional Selectivity in Neutrophils
Abstract
Neutrophils are important effector cells of the innate immune system and in the regulation of inflammation. Many of their functions, such as chemotactic migration, secretion of granule constituents and activation of the oxygen radical-producing NADPH-oxidase, are regulated by cell surface receptors. The formyl peptide receptors (FPRs), the ATP receptor (P2Y2R) and the receptor for platelet activating factor (PAFR) belong to the large family of G-protein coupled receptors (GPCRs) and, amongst other receptors, enable neutrophils to sense and respond to host- and pathogen-derived danger signals. Therefore, any regulatory imbalance in GPCR signaling can potentially contribute to the development of severe infections or autoimmune/inflammatory diseases.
The work presented in this thesis is focused on basic GPCR-signaling mechanisms in human neutrophils with the aim to generate new knowledge that could be of value for future GPCR-based drug development. To answer the scientific questions raised, numerous cell-biology-based experimental methods were applied, including measurements of neutrophil intracellular calcium release, superoxide production, degranulation, cell migration and cytoskeleton-mediated receptor regulation.
The functional responses triggered by GPCRs expressed by neutrophils can be modulated in various ways at the level of receptors/ligand interaction, in dependence of other GPCRs, as well as at the signaling level. Both FPR2 and P2Y2R have been shown to be able to exert functional selective signaling through distinct regulatory mechanisms. An FPR2-specific synthetic lipopeptide allosteric modulator was identified as a biased agonist that does not induce recruitment of β-arrestin or chemotactic migration and exhibits oppositional efficacies for direct FPR2 activation and receptor cross-talk-mediated signaling. Functional selectivity liked to the P2Y2R is not related to biased agonism but instead emerges from an endogenous actin cytoskeleton-dependent regulatory mechanism which selectively inhibits the signals that lead to the generation of oxygen radicals, while leaving other signaling pathways unaffected.
In conclusion, this thesis adds new knowledge to the field of neutrophil receptor biology and provides novel insights into the modulation of basic GPCR signaling mechanisms with intend to contribute to strategies for future drug design and treatment of inflammatory disorders and disease.
Parts of work
I. Gabl M. et al. A Pepducin Derived from the Third Intracellular Loop of FPR2 Is a Partial Agonist for Direct Activation of This Receptor in Neutrophils But a Full Agonist for Cross-Talk Triggered Reactivation of FPR2. PLoS One, 2014, 9(10):e109516. ::doi::10.1371/journal.pone.0109516 II. Gabl M. et al. P2Y2 receptor signaling in neutrophils is regulated from inside by a novel cytoskeleton-dependent mechanism. Experimental Cell Research, 2015, 336(2):242-52. ::doi:: 10.1016/j.yexcr.2015.07.014 III. Gabl M. et al. A pepducin designed to modulate P2Y2R function interacts with FPR2 in human neutrophils and transfers ATP to an NADPH-oxidase-activating ligand through a receptor cross-talk mechanism. Biochimica et Biophysica Acta (BBA) – Molecular Cell Research, 2016, 1863(6 Pt A):1228-37. ::doi::10.1016/j.bbamcr.2016.03.014 IV. Gabl M. et al. FPR2 signaling without β-arrestin recruitment alters the functional repertoire of neutrophils. Biochemical Pharmacology, 2017. ::doi::10.1016/j.bcp.2017.08.018
Degree
Doctor of Philosophy (Medicine)
University
University of Gothenburg. Sahlgrenska Academy
Institution
Institute of Medicine. Department of Rheumatology and Inflammation Research
Disputation
Fredagen den 17 November 2017, kl. 09.00, Hörsal plan 3, Medicinaregatan 10A, Göteborg
Date of defence
2017-11-17
michael.gabl@gu.se
Date
2017-10-17Author
Gabl, Michael
Keywords
neutrophils
G-protein coupled receptors
reactive oxygen species
ligands
functional selectivity
allosteric modulation
Publication type
Doctoral thesis
ISBN
978-91-629-0299-5 (pdf)
978-91-629-0298-8 (print)
Language
eng